| For: | Ismaili N. Emergence of human epidermal growth factor receptor 2 as a key biomarker and therapeutic target in advanced urothelial carcinoma. World J Clin Oncol 2026; 17(7): 116520 [DOI: 10.5306/wjco.116520] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v17/i7/116520.htm |
| Number | Citing Articles |
| 1 |
Nabil Ismaili, Sanaa El Majjaoui. Immunotherapy in urological cancers: new paradigms and a systematic review of clinical trials and real-world evidence. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1871832
|